Isq Global Fund II GP LLC sells $3.7m Kinetik Holdings stock

ISQ Global Fund II GP LLC, a ~10% owner/director of Kinetik Holdings (KNTK), sold 68,005 shares for ~$3.70M at weighted-average prices of $54.32–$55.07, leaving it with 925,787 shares indirectly. Meanwhile, Kinetik reported strong Q2’26 results with adjusted EPS of $0.64 vs $0.25 expected and revenue of $581.44M vs $438.25M, and raised full-year 2026 adjusted EBITDA guidance to $1.04B–$1.10B (from prior levels). Clear Street downgraded KNTK from Buy to Hold with a $57 PT, citing limited upside after ~35% YTD outperformance.

Analysis

The main signal here is not the insider sale itself, but that a large holder is choosing to distribute into strength after a substantial re-rating. For a smaller-cap midstream name like KNTK, that creates a real marginal-supply overhang because the buyer base is narrower and the stock has already pulled forward a lot of its best-case execution story. In other words, the market is now being asked to pay up for a next leg of growth that is increasingly dependent on continued commodity support and perfect quarter-to-quarter execution.

The second-order winner is the broader midstream complex with cleaner fee-based duration and less insider overhang. Names like WMB and ET can absorb rotating capital if investors decide KNTK’s recent move has outrun its next 12 months of fundamentals, especially since the easiest catalyst — a strong earnings surprise — is already in the tape. The loser on a relative basis is any capital allocated to high-beta infrastructure names that need repeated positive revisions to justify current multiples; if gas/NGL conditions soften, KNTK’s earnings power can mean-revert faster than the market expects.

The contrarian view is that the sell is still small versus the remaining stake, so it may be routine diversification rather than a true negative read-through. That said, the burden of proof has shifted to the company: the stock likely needs another guide-up or a visibly higher exit-rate EBITDA run-rate within 1-2 quarters to keep the rally going. If the next print is merely ‘good’ rather than better, the recent outperformance is vulnerable to compression first, while the fundamental downside would show up over the following 6-18 months if commodity tailwinds fade.

Key Decisions for Investors

• Relative-value: long WMB / short KNTK for 1-3 months. Thesis is that KNTK’s recent outperformance and insider distribution create downside asymmetry, while WMB offers cleaner fee-based duration and better capital absorption if midstream sentiment cools. Falsifier: KNTK closes above recent highs on expanding volume and confirms another guidance raise.
• If already long KNTK, trim into strength rather than add here. Use any pullback only after the next earnings report confirms that the higher EBITDA run-rate is repeatable, not just commodity-assisted. Risk/reward is poor near the top of the range without a new catalyst.
• Watchlist trade: buy KNTK put spreads into the next earnings window only if implied volatility is not already elevated. Structure it as a tactical mean-reversion hedge, not a structural short; cover if management re-accelerates guidance or the stock holds above the 52-week high after the print.
• Prefer ET or WMB over KNTK for fresh midstream exposure over a 6-12 month horizon. The trade is lower headline beta and less insider-supply risk, with a better chance of compounding if sector multiples tighten.
• Alert level: if KNTK loses the post-earnings breakout and trades back below the prior support zone on volume, treat that as confirmation that the market is fading the execution story and reassess the long-only thesis.